Print

Financial Disclosure

Click here for Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents Financial Disclosure (Reporting Period: February 2016 to October 2017)

Name

Entity

Relationship

Benefit to Individual

Benefit to Institution

Fiona Bisshop

ViiV

Advisory board payment

X

 

Gilead

Attend Harvard Clinical Exchange Meeting

X

 

Mark Bloch

AbbVie

Grant/grants pending

 

X

Bristol-Myers Squibb

Grant/grants pending

 

X

Travel expenses, Advisory board membership

X

 

Eli Lilly

Advisory Board membership

X

 

Educational presentations

Gilead Science

Advisory board membership, Travel expenses

X

 

Grant/grants pending

Janssen

Grant/grants pending

X

 

MSD

Consultancy, Educational presentations

X

 

Grant/grants pending

 

X

Travel expenses

X

 

ViiV Healthcare

Advisory board membership

X

 

Educational presentations

X

 

Grants/grants pending

 

X

Travel expenses

X

 

Mark Boyd

ViiV Healthcare

Educational presentations

X

 

HIV advisory board membership

X

 

Gilead Sciences

Educational presentations

X

 

HIV advisory board membership

X

 

James McMahon

Amgen

Grants/grants pending

 

X

Shire

Grants/grants pending

 

X

Gilead

Grants/grants pending

 

X

ViiV

Grants/grants pending

X

Merck

Grants/grants pending

 

X

Rick Varma

None

N/A

 

 

Danielle Collins

None

N/A

 

 

Andrew Grulich

Seqirus

Grant/grants pending

 

X

Cancer Council NSW

Grant/grants pending

X

 

American Foundation for AIDS Research

Grant/grants pending

X

 

Gilead

Educational presentations

X

 

Merck

Educational presentations

X

 

NHMRC

Travel expenses

 

X

Cure Cancer Australia

Advisory Board Member

 

X

NSW Ministry of Health

Grants pending

 

X

ViiV Healthcare

Educational presentations

Advisory Board Member

X

 

Bill Whittaker

ViiV Healthcare

Advisory Board Member 

X

 

David Nolan

none

 

 

 

Rupert Hardy none

ASHM - Supporting the HIV, Viral Hepatitis and Sexual Health Workforce